BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30813110)

  • 21. Colonoscopies in Australia - how much does the National Bowel Cancer Screening Program contribute to colonoscopy use?
    Worthington J; He E; Lew JB; St John J; Horn C; Grogan P; Canfell K; Feletto E
    Public Health Res Pract; 2023 Mar; 33(1):. PubMed ID: 36477980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geographic variation in compliance with Australian colorectal cancer screening programs: the role of attitudinal and cognitive traits.
    Goodwin BC; March S; Ireland M; Crawford Williams F; Manksi D; Ford M; Dunn J
    Rural Remote Health; 2019 Jul; 19(3):4957. PubMed ID: 31340653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of 'The Father Effect' Media Campaign to Increase Awareness of, and Participation in, an Online Father-Inclusive Parenting Program.
    Tully LA; Piotrowska PJ; Collins DAJ; Frick PJ; Anderson V; Moul C; Lenroot RK; Kimonis ER; Hawes D; Dadds MR
    Health Commun; 2019 Nov; 34(12):1423-1432. PubMed ID: 29985642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of an Australian mass media campaign targeting physical activity in 1998.
    Bauman AE; Bellew B; Owen N; Vita P
    Am J Prev Med; 2001 Jul; 21(1):41-7. PubMed ID: 11418256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.
    Hughes K; Leggett B; Del Mar C; Croese J; Fairley S; Masson J; Aitken J; Clavarino A; Janda M; Stanton WR; Tong S; Newman B
    Aust N Z J Public Health; 2005 Aug; 29(4):358-64. PubMed ID: 16222934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of stopping sending colorectal cancer screening test kits by regular mail.
    Koïvogui A; Ecochard R; Le Mab G; Benamouzig R
    Public Health; 2019 Aug; 173():33-41. PubMed ID: 31252152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors contributing to low readiness and capacity of culturally diverse participants to use the Australian national bowel screening kit.
    Phillipson L; Pitts L; Hall J; Tubaro T
    Public Health Res Pract; 2019 Mar; 29(1):. PubMed ID: 30972408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using a mass media campaign to raise women's awareness of the link between alcohol and cancer: cross-sectional pre-intervention and post-intervention evaluation surveys.
    Dixon HG; Pratt IS; Scully ML; Miller JR; Patterson C; Hood R; Slevin TJ
    BMJ Open; 2015 Mar; 5(3):e006511. PubMed ID: 25762231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimising the expansion of the National Bowel Cancer Screening Program.
    Cenin DR; St John DJ; Ledger MJ; Slevin T; Lansdorp-Vogelaar I
    Med J Aust; 2014 Oct; 201(8):456-61. PubMed ID: 25332032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Awareness and impact of the 'Bubblewrap' advertising campaign among Aboriginal smokers in Western Australia.
    Boyle T; Shepherd CC; Pearson G; Monteiro H; McAullay D; Economo K; Stewart S
    Tob Control; 2010 Feb; 19(1):83-6. PubMed ID: 19965798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial impact of Australia's National Bowel Cancer Screening Program.
    Ananda SS; McLaughlin SJ; Chen F; Hayes IP; Hunter AA; Skinner IJ; Steel MC; Jones IT; Hastie IA; Rieger NA; Shedda S; Compston DJ; Gibbs P
    Med J Aust; 2009 Oct; 191(7):378-81. PubMed ID: 19807627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Colorectal Neoplasia in a Cohort Before and After the Change of Fecal Occult Blood Test in a French Colorectal Cancer Screening Program.
    Koïvogui A; Mab GL; Benamouzig R
    Am J Gastroenterol; 2018 Dec; 113(12):1891-1899. PubMed ID: 30337703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the introduction of a new policy of direct faecal immunochemical home screening test provision in a national bowel screening programme, both during and outside of advertising campaigns.
    Fahy L; Fitzpatrick P; Meade C; Farrell HC; O'Donoghue D; Mooney T
    Cancer Epidemiol; 2020 Dec; 69():101844. PubMed ID: 33099212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the United kingdom national bowel cancer awareness campaign on colorectal services.
    Pande R; Leung E; McCullough P; Smith S; Harmston C
    Dis Colon Rectum; 2014 Jan; 57(1):70-5. PubMed ID: 24316948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.
    Toes-Zoutendijk E; van Leerdam ME; Dekker E; van Hees F; Penning C; Nagtegaal I; van der Meulen MP; van Vuuren AJ; Kuipers EJ; Bonfrer JMG; Biermann K; Thomeer MGJ; van Veldhuizen H; Kroep S; van Ballegooijen M; Meijer GA; de Koning HJ; Spaander MCW; Lansdorp-Vogelaar I;
    Gastroenterology; 2017 Mar; 152(4):767-775.e2. PubMed ID: 27890769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A targeted promotional DVD fails to improve Māori and Pacific participation rates in the New Zealand bowel screening pilot: results from a pseudo-randomised controlled trial.
    Bartholomew K; Zhou L; Crengle S; Buswell E; Buckley A; Sandiford P
    BMC Public Health; 2019 Sep; 19(1):1245. PubMed ID: 31500594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal cancer screening in rural and remote areas: analysis of the National Bowel Cancer Screening Program data for South Australia.
    Martini A; Javanparast S; Ward PR; Baratiny G; Gill T; Cole S; Tsourtos G; Aylward P; Jiwa M; Misan G; Wilson C; Young GP
    Rural Remote Health; 2011; 11(2):1648. PubMed ID: 21585228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.